Juan Carlos Álvarez-Pérez

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2025
High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models.

Juan Carlos Álvarez-Pérez, Juan Sanjuán-Hidalgo, Alberto M Arenas

|Mar 21, 2023
BCL7A is silenced by hypermethylation to promote acute myeloid leukemia.

Juan Rodrigo Patiño-Mercau, Carlos Baliñas-Gavira, Alvaro Andrades

|Jan 05, 2022
Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes.

Alvaro Andrades, Juan Carlos Álvarez-Pérez, Juan Rodrigo Patiño-Mercau

|Dec 16, 2020
Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models.

Paola Peinado, Alvaro Andrades, Marta Cuadros

|Aug 01, 2020
LncRNA DLG2-AS1 as a Novel Biomarker in Lung Adenocarcinoma.

Alberto M Arenas, Marta Cuadros, Alvaro Andrades

Pageof 1